SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009264
Filing Date
2023-05-11
Accepted
2023-05-11 07:51:56
Documents
92
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20230331x10q.htm   iXBRL 10-Q 1812710
2 EX-4.1 aplt-20230331xex4d1.htm EX-4.1 32730
3 EX-31.1 aplt-20230331xex31d1.htm EX-31.1 9713
4 EX-31.2 aplt-20230331xex31d2.htm EX-31.2 10671
5 EX-32.1 aplt-20230331xex32d1.htm EX-32.1 6232
6 EX-32.2 aplt-20230331xex32d2.htm EX-32.2 6407
  Complete submission text file 0001558370-23-009264.txt   8127415

Data Files

Seq Description Document Type Size
7 EX-101.SCH aplt-20230331.xsd EX-101.SCH 68134
8 EX-101.CAL aplt-20230331_cal.xml EX-101.CAL 52180
9 EX-101.DEF aplt-20230331_def.xml EX-101.DEF 278431
10 EX-101.LAB aplt-20230331_lab.xml EX-101.LAB 514708
11 EX-101.PRE aplt-20230331_pre.xml EX-101.PRE 474349
86 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20230331x10q_htm.xml XML 1292779
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 23908893
SIC: 2834 Pharmaceutical Preparations